Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
about
Hypercapnia causes cellular oxidation and nitrosation in addition to acidosis: implications for CO2 chemoreceptor function and dysfunction.Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.Hepatic oxidative stress in an animal model of sleep apnoea: effects of different duration of exposure.Urinary biomarkers of oxidative status.Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver.Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more.Making sense of oxidative stress in obstructive sleep apnea: mediator or distracter?Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea.Molecular mechanisms of chronic intermittent hypoxia and hypertensionMaternal Stress and Depressive Symptoms and Infant Development at Six Months: the Mothers and Children's Environmental Health (MOCEH) Prospective Study.The effect of obstructive sleep apnea on DNA damage and oxidative stress.Molecular signatures of obstructive sleep apnea in adults: a review and perspective.Reactive oxygen species contribute to sleep apnea-induced hypertension in ratsThe ventilatory response to hypoxia in mammals: mechanisms, measurement, and analysis.Evaluation of oxidative stress markers in obstructive sleep apnea syndrome and additional antioxidant therapy: a review article.Antioxidant vitamins prevent oxidative and carbonyl stress in an animal model of obstructive sleep apnea.Effects of nCPAP therapy on cardiorespiratory outcomes in obstructive sleep apnea syndrome: compliance and technological advancements.Endothelium-derived markers and antioxidant status in the blood of obstructive sleep apnea males.Obstructive sleep apnea and the metabolic syndrome.Effect of NADPH oxidase inhibitor apocynin on the expression of hypoxia-induced factor-1α and endothelin-1 in rat carotid body exposed to chronic intermittent hypoxia.Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS.Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea.Melatonin ameliorates hippocampal nitric oxide production and large conductance calcium-activated potassium channel activity in chronic intermittent hypoxia.Serum Romo1 is significantly associated with disease severity in patients with obstructive sleep apnea syndrome.Inflammatory and oxidative stress‑associated factors in chronic intermittent hypoxia in Chinese patients, rats, lymphocytes and endotheliocytes.Oxidative and carbonyl stress in pregnant women with obstructive sleep apnea.Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea.DNA damage in peripheral blood lymphocytes from patients with OSAHS.Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure.
P2860
Q33917387-B9CC7779-F719-4D84-88AD-2CB406794EE2Q34697950-D2C4F1F8-85BA-4137-95DE-B9BDA1B20866Q35130266-0AC0E7A8-6690-400E-9F0D-7DCD522AC091Q36178739-1E115A7D-3462-40D3-BB85-229388481B35Q36443187-699D8901-F1C9-47FF-9398-CFEC0CB6D775Q36482623-A53C5166-2342-42EF-BD99-0C8ECAA906A2Q36490066-75FFFC1A-37CB-45C9-8612-D4EA48D7C6B2Q36662363-ABABE6C0-2752-4566-BD88-20E1579E8CECQ36790835-01DF7F7A-69F6-4D66-B054-7ED76BC568A0Q36859796-0E62AADA-6FF2-4EAA-976A-1627B9941A8AQ36941627-040C89DE-A357-41A8-A148-A57D05E0F8CDQ37146506-28D4AD97-704C-4FD2-93DA-67F8F5F1F051Q37220930-CFFE2988-C1C3-4A30-9B31-02079E3DCF2BQ37731210-B8D0FA99-3FC4-4A64-858A-037529082EDDQ38851809-62D95B7F-422F-4311-A9D7-78C9431C60C6Q39606726-7695F412-CE12-48B1-890A-644CBEDB42A3Q39779242-99DDD379-7B36-4773-ABE4-1C72A1CB2BE3Q42211383-397286C4-2B7D-4420-9A1B-C119FBA7E382Q43061638-29EB9A07-538E-4D74-B3A8-63747213DDBDQ43537994-17593113-D73E-4CEE-AEA7-DAC5C94E072EQ44180901-9D770BFB-9432-465C-B5A5-5FF09B6F34DFQ45999442-02C900F3-C6CB-4081-B21B-A683B9B54286Q46703463-4AEF2EC7-3251-4A01-860F-C1AC9EAD1DD8Q47230560-E2C692D5-5FC9-4536-9425-4169348A9E1BQ47689143-3178C77F-0D56-4885-BE91-A862B3430088Q47760172-8A6DCF1E-D675-4164-8871-5BBE81E7BF07Q47787773-06736252-A297-46DF-BA6D-67D5A8D80DFFQ48029956-D6850D29-E0D7-4D64-B6B6-DFAB03CBABD5Q48129248-92BCB2C9-0588-4B4D-AC40-B692D45CEC9CQ48310770-D61A6B87-4148-4B6B-B498-3E1825F460F0
P2860
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
@en
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
@nl
type
label
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
@en
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
@nl
prefLabel
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
@en
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
@nl
P2093
P1476
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome.
@en
P2093
A Rodenbeck
P2860
P2888
P304
P356
10.1007/S00702-005-0316-2
P577
2005-06-15T00:00:00Z